Briya Showcases AI-Driven R&D and Clinical Data Capabilities

According to a recent LinkedIn post from Briya, the company participated in a joint webinar with DayOne – Healthtech Innovation focused on how AI and improved data can support more confident decision-making across the R&D lifecycle. The post notes that a live demo of Briya AIRE, led by Or Shaked, MD-MPH, illustrated how the platform applies NLP to enrich clinical and real-world data, de-risk protocol design, and link trial planning to commercial impact.

For investors, the post suggests that Briya is positioning its technology as an enabler of more efficient and commercially informed clinical research, which could appeal to pharma and biotech customers seeking to reduce trial risk and timelines. Emphasis on connecting protocol design with downstream commercial outcomes may support Briya’s value proposition in budget-sensitive environments and could strengthen its competitive stance in AI-driven clinical data and RWE solutions as adoption scales.